Mothers with multiple sclerosis had an elevated incidence and prevalence of peripartum mental illness vs. mothers without MS ...
Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...
The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women.
Mikael Simons, MD, a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases ...
The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...
A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during ...
A promising new treatment accelerates myelin repair, potentially restoring vision and improving brain function in people with ...
From 1996-2024, 82 cases of anaphylaxis associated with glatiramer acetate were reported to the FDA Adverse Event Reporting ...
The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.
People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other chronic conditions, according to a new study analyzing over 890,000 births ...
The FDA is adding a new boxed warning to include information that anaphylaxis can occur at any time, from as early as after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback